A retrospective observational study on the safety and efficacy of first-line treatment with bevacizumab combined with FOLFIRI in metastatic colorectal cancer

BACKGROUND: Combination of bevacizumab and FOLFIRI has currently become one of the standard therapeutic regimens. However, published information is still limited. The objective of the present retrospective observational study is to analyse the response and toxicity of first-line treatment with FOLFI...

Descripción completa

Detalles Bibliográficos
Autores principales: López, R, Salgado, M, Reboredo, M, Grande, C, Méndez, J C, Jorge, M, Romero, C, Quintero, G, de la Cámara, J, Candamio, S
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2010
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2990582/
https://www.ncbi.nlm.nih.gov/pubmed/20940719
http://dx.doi.org/10.1038/sj.bjc.6605938

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2990582/
https://www.ncbi.nlm.nih.gov/pubmed/20940719
http://dx.doi.org/10.1038/sj.bjc.6605938

Ejemplares similares